tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eliana Merle, 181 are a BUY (82.65%), 38 are a HOLD (17.35%).
Analyst Eliana Merle, currently employed at BARCLAYS, carries an average stock price target met ratio of 48.18% that have a potential upside of 45% achieved within 226 days. Previously, Eliana Merle worked at CREDIT SUISSE, UBS, CANTOR FITZGERALD.
Eliana Merle’s has documented 417 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on QURE, Uniqure NV at 18-Jun-2026.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 1/28/2025. The price target of $2.2 was fulfilled within 1 day with a profit of $0.2 (8.33%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
1 months 24 days ago
(15-May-2026)
4/22 (18.18%)
$13.11 (73.28%)
308
Buy Since 20-Jan-2026
$41
$37.23 (987.53%)
$26
2 months 22 days ago
(17-Apr-2026)
15/18 (83.33%)
$0.1 (0.24%)
100
Hold Since 02-Nov-2023
$41
$37.23 (987.53%)
$20
3 months 7 days ago
(02-Apr-2026)
14/19 (73.68%)
$0.59 (1.46%)
147
Buy Since 19-Jul-2022
$41
$37.23 (987.53%)
$48
3 months 8 days ago
(01-Apr-2026)
4/29 (13.79%)
$0.61 (1.51%)
90
Buy Since 19-Jan-2024
$41
$37.23 (987.53%)
$45
3 months 8 days ago
(01-Apr-2026)
16/28 (57.14%)
$0.61 (1.51%)
368
Which stock is Eliana Merle is most bullish on?
Which stock is Eliana Merle is most reserved on?
What Year was the first public recommendation made by Eliana Merle?
